BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21477600)

  • 1. MicroRNAs, the DNA damage response and cancer.
    Wouters MD; van Gent DC; Hoeijmakers JH; Pothof J
    Mutat Res; 2011 Dec; 717(1-2):54-66. PubMed ID: 21477600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity.
    van Jaarsveld MT; Wouters MD; Boersma AW; Smid M; van Ijcken WF; Mathijssen RH; Hoeijmakers JH; Martens JW; van Laere S; Wiemer EA; Pothof J
    Mol Oncol; 2014 May; 8(3):458-68. PubMed ID: 24462518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs and DNA damage response: implications for cancer therapy.
    Wang Y; Taniguchi T
    Cell Cycle; 2013 Jan; 12(1):32-42. PubMed ID: 23255103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs, DNA Damage Response, and Cancer Treatment.
    He M; Zhou W; Li C; Guo M
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage response regulation by microRNAs as a therapeutic target in cancer.
    Majidinia M; Yousefi B
    DNA Repair (Amst); 2016 Nov; 47():1-11. PubMed ID: 27697364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the microRNA-regulating DNA damage/repair pathways in cancer.
    Bottai G; Pasculli B; Calin GA; Santarpia L
    Expert Opin Biol Ther; 2014 Nov; 14(11):1667-83. PubMed ID: 25190496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNAs in cancer cell response to ionizing radiation.
    Czochor JR; Glazer PM
    Antioxid Redox Signal; 2014 Jul; 21(2):293-312. PubMed ID: 24206455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs: an emerging player in DNA damage response.
    Zhang C; Peng G
    Mutat Res Rev Mutat Res; 2015; 763():202-11. PubMed ID: 25795121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs: new players in the DNA damage response.
    Hu H; Gatti RA
    J Mol Cell Biol; 2011 Jun; 3(3):151-8. PubMed ID: 21183529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and the DNA damage response: How is cell fate determined?
    Visser H; Thomas AD
    DNA Repair (Amst); 2021 Dec; 108():103245. PubMed ID: 34773895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Death Response to DNA Damage.
    Wang JYJ
    Yale J Biol Med; 2019 Dec; 92(4):771-779. PubMed ID: 31866794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.
    Tian H; Gao Z; Li H; Zhang B; Wang G; Zhang Q; Pei D; Zheng J
    Cancer Lett; 2015 Mar; 358(1):8-16. PubMed ID: 25528631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
    Kinsella TJ
    Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.
    Curtin NJ
    Br J Pharmacol; 2013 Aug; 169(8):1745-65. PubMed ID: 23682925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage response and DNA repair - dog as a model?
    Grosse N; van Loon B; Rohrer Bley C
    BMC Cancer; 2014 Mar; 14():203. PubMed ID: 24641873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic opportunities within the DNA damage response.
    Pearl LH; Schierz AC; Ward SE; Al-Lazikani B; Pearl FM
    Nat Rev Cancer; 2015 Mar; 15(3):166-80. PubMed ID: 25709118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage response and prostate cancer: defects, regulation and therapeutic implications.
    Karanika S; Karantanos T; Li L; Corn PG; Thompson TC
    Oncogene; 2015 May; 34(22):2815-22. PubMed ID: 25132269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.
    Basourakos SP; Li L; Aparicio AM; Corn PG; Kim J; Thompson TC
    Curr Med Chem; 2017; 24(15):1586-1606. PubMed ID: 27978798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'.
    Bartek J; Lukas J; Bartkova J
    Cell Cycle; 2007 Oct; 6(19):2344-7. PubMed ID: 17700066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.